本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Benitec Biopharma Limited

13.91
-0.0900-0.64%
盤後13.910.00000.00%18:44 EDT
成交量:3.87萬
成交額:53.94萬
市值:3.65億
市盈率:-9.49
高:14.30
開:14.06
低:13.68
收:14.00
52周最高:17.15
52周最低:8.06
股本:2,625.05萬
流通股本:1,288.63萬
量比:0.93
換手率:0.30%
股息:- -
股息率:- -
每股收益(TTM):-1.4658
每股收益(LYR):-5.5096
淨資產收益率:-48.57%
總資產收益率:-31.34%
市淨率:3.74
市盈率(LYR):-2.52

資料載入中...

2019/09/19

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/16

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/29

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/29

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/07/31

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/07/25

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/07/23

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/06

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/24

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/08

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/02/26

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2019/01/31

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/12/21

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/11/09

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/10/30

年度報告

Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2018/10/29

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/10/09

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/09/21

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/09/04

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]